Factors associated with pancreatic infection in patients with severe acute pancreatisis

Por Zou, Chen, Lu, Zipeng, Zhang, Zhiqiang, Zhao, Liangtao, Tian, Lei, Jiang, Kuirong, Miao, Yi
Publicado no Int J Clin Exp Med (2015)

CXC motif chemokine receptor 4 gene polymorphism and cancer risk

Por Wu, Yang, Zhang, Chun, Xu, Weizhang, Zhang, Jianzhong, Zheng, Yuxiao, Lu, Zipeng, Liu, Dongfang, Jiang, Kuirong
Publicado no Medicine (Baltimore) (2016)

The clinical value, regulatory mechanisms, and gene network of the cancer-testis gene STK31 in pancreatic cancer

Por Zhang, Kai, Lu, Zipeng, Zhu, Yi, Tian, Lei, Zhang, Jingjing, Xi, Chunhua, Gao, Wentao, Jiang, Kuirong, Miao, Yi
Publicado no Oncotarget (2017)

MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma

Por Xue, Xiaofeng, Zhang, Ye, Zhi, Qiaoming, Tu, Min, Xu, Yue, Sun, Jie, Wei, Jishu, Lu, Zipeng, Miao, Yi, Gao, Wentao
Publicado em 2014

Modified methods for isolation of pancreatic stellate cells from human and rodent pancreas

Por Zhao, Liangtao, Cai, Baobao, Lu, Zipeng, Tian, Lei, Guo, Song, Wu, Pengfei, Qian, Dong, Xu, Qingcheng, Jiang, Kuirong, Miao, Yi
Publicado no J Biomed Res (2016)

Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2

Por Tu, Min, Li, Haifeng, Lv, Nan, Xi, Chunhua, Lu, Zipeng, Wei, Jishu, Chen, Jianmin, Guo, Feng, Jiang, Kuirong, Song, Guoxin, Gao, Wentao, Miao, Yi
Publicado no Mol Cancer (2017)

Radical antegrade modular pancreatosplenectomy for adenocarcinomaof the body of the pancreas in a patient with portal annular pancreas, aberrant hepatic artery, and absence of the...

Por Yuan, Hao, Wu, Pengfei, Chen, Jianmin, Lu, Zipeng, Chen, Lei, Wei, Jishu, Guo, Feng, Cai, Baobao, Yin, Jie, Xu, Dong, Jiang, Kuirong, Miao, Yi
Publicado no Medicine (Baltimore) (2017)

Vasohibin-2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor-2 and growth/differentiation factor-15 expression

Por TU, MIN, LIU, XIAN, HAN, BEI, GE, QIANQIAN, LI, ZHANJUN, LU, ZIPENG, WEI, JISHU, SONG, GUOXIN, CAI, BAOBAO, LV, NAN, JIANG, KUIRONG, WANG, SHUI, MIAO, YI, GAO, WENTAO
Publicado em 2014

A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma

Por Shi, Guodong, Zhang, Jingjing, Lu, Zipeng, Liu, Dongfang, Wu, Yang, Wu, Pengfei, Yin, Jie, Yuan, Hao, Zhu, Qicong, Chen, Lei, Fu, Yue, Peng, Yunpeng, Wang, Yan, Jiang, Kuirong, Miao, Yi
Publicado no Oncotarget (2017)

Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3

Por Hu, Hao, Wang, Yandong, Ding, Xiangya, He, Yuan, Lu, Zipeng, Wu, Pengfei, Tian, Lei, Yuan, Hao, Liu, Dongfang, Shi, Guodong, Xia, Tianfang, Yin, Jie, Cai, Baobao, Miao, Yi, Jiang, Kuirong
Publicado no Mol Cancer (2018)

Small amounts of tissue preserve pancreatic function: Long-term follow-up study of middle-segment preserving pancreatectomy

Por Lu, Zipeng, Yin, Jie, Wei, Jishu, Dai, Cuncai, Wu, Junli, Gao, Wentao, Xu, Qing, Dai, Hao, Li, Qiang, Guo, Feng, Chen, Jianmin, Xi, Chunhua, Wu, Pengfei, Zhang, Kai, Jiang, Kuirong, Miao, Yi
Publicado no Medicine (Baltimore) (2016)